Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 2

Raltegravir: first in class HIV integrase inhibitor

Total article views   HTML views PDF downloads Totals
6,811 Dovepress* 6,811+ 1,898 8,709
Totals 6,811 1,898 8,709
*Since 11 April 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on Google Scholar